Fluid Bolus and Reduced Oxytocin May Improve Fetal Heart Rate During Labor Analgesia

Non-reassuring fetal heart rate (FHR) patterns are a critical indicator for diagnosing fetal distress, particularly following the initiation of neuraxial analgesia like combined-spinal epidural analgesia (CSEA). CSEA is widely used, with approximately 90% of parturients at Prentice Women's Hospital receiving it. A proposed mechanism for FHR changes post-analgesia involves a decrease in sympathetic catecholamine release, impacting fetal circulation. Current standard-of-care protocols for fluid administration and oxytocin management around CSEA initiation may contribute to the variability in reported non-reassuring FHR incidents, which range from 3-23%. Understanding how these variables interact is crucial to improving patient care and fetal outcomes.

This study's hypothesis proposes that specific management strategies for fluid and oxytocin administration can mitigate adverse fetal heart rate changes during labor analgesia. The researchers hypothesized that patients receiving a 1000 mL fluid bolus combined with lower rates of oxytocin administration would exhibit fewer non-reassuring fetal heart rate changes. Specifically, the study aimed to investigate if decreasing the oxytocin infusion rate by 50% prior to and during the initiation of neuraxial analgesia, alongside a 1000 mL fluid bolus, could lead to more reassuring fetal heart rate patterns. The study excluded patients with chronic analgesic use, prior systemic opioid analgesia, non-vertex presentation, contraindications to neuraxial analgesia, or a Category 3 fetal heart rate tracing pre-CSEA.